On-Demand Webinars

31. Optimization Of Anion Exchange Purification For The Large-Scale Production Of Plasmid DNA 11/4/2025

    In this webinar, we discuss pDNA purification, including how to identify optimal conditions for various chromatography media and optimize recovery and impurity removal.

32. The Evolution Of GMP Asset Management 10/31/2025

    Learn how teams are shifting from reactive maintenance to predictive intelligence with connected systems, real-time insights, and AI-driven asset strategies while keeping compliance at the center.

33. Faster Tech Transfers Through Seamless Digital Transformation 10/30/2025

    Manual process documentation slows innovation. Learn how modular libraries and digital connectivity enable faster, error-resistant execution, bridging the gap between process design and automation.

34. Developing Your Risk-Based Approach To Single-Use System Integrity 10/29/2025

    Explore how a holistic approach to single-use system integrity can strengthen contamination control, improve operational efficiency, and meet evolving regulatory expectations in manufacturing.

35. Optimize DNA Clearance In High-Salt, GMP-Grade Purification Processes 10/28/2025

    Explore how salt-active endonucleases overcome DNA clearance challenges in viral vector purification by digesting down to 3–5 nucleotides and performing reliably in high-salt conditions.

36. Strategies For Enhancing Bioprocessing Productivity 10/27/2025

    New complex therapeutics demand a shift from traditional bioprocessing. Learn how innovative strategies and resin technologies can help you manage costs and efficiently scale production.

37. The Case For Optimized And Excipient GMP Cell Culture Solutions 10/27/2025

    Learn how optimized, customizable formulations and Excipient GMP manufacturing streamline development, ensuring quality and consistency for a de-risked path to the clinic.

38. Smarter CMC Strategies To Accelerate Next-Gen Biologics To The Clinic 10/23/2025

    Learn how process design and cross-functional collaboration mitigate risks and accelerate the path from early development to FIH manufacturing through real-world case studies of practical approaches.

39. Your Journey To GMP With Emphasis On Linker Payload Development 10/22/2025

    Develop lower-risk conjugation strategies by incorporating the critical insights we highlight in our review of semi-synthetic versus synthetic linker–payloads and their respective advantages and limitations.

40. Enhancing Non-Viral CAR T Manufacturing With Electroporation And Microbubble T Cell Isolation 10/22/2025

    Unlock superior non-viral CAR T manufacturing outcomes by combining gentle microbubble T cell isolation with advanced electroporation. See how this approach boosts cell viability and transfection efficiency.